Drug Type Monoclonal antibody |
Synonyms EP 9001A, EP-9001A, EP9001A |
Target |
Mechanism NGF inhibitors(Nerve growth factor inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cancer Pain | Phase 2 | CN | 30 Oct 2023 |